logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10695409 B1

PDFFull Text
Date of Patent:
Jun. 30, 2020

Filed:

May. 31, 2017

Universal cancer peptides derived from telomerase

Applicants:

Invectys, Paris, FR;

Universite DE Franche-comte, Besancon, FR;

Centre Hospitalier Regional Universitaire DE Besancon, Besancon, FR;

Inventors:

Pierre Langlade Demoyen, Neuilly sur Seine, FR;

Olivier Adotevi, Besancon, FR;

Magalie Dosset, Besancon, FR;

Assignees:

INVECTYS, Paris, FR;

UNIVERSITE DE FRANCHE-COMTE, Besancon, FR;

CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON, Besancon, FR;

Attorney:

Troutman Sanders LLP

Primary Examiner:

Hong Sang

Int. Cl.
CPC ...
C07K 7/08 (2006.01); A61K 38/04 (2006.01); A61K 39/00 (2006.01); G01N 33/50 (2006.01); C12N 9/12 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 38/04 (2013.01); A61K 39/00 (2013.01); C07K 7/08 (2013.01); C12N 9/1276 (2013.01); C12Y 207/07049 (2013.01); G01N 33/505 (2013.01); G01N 33/57492 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/57 (2013.01); A61K 2039/572 (2013.01); A61K 2039/585 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/9128 (2013.01);
Abstract

The invention relates to a peptide of 15 to 20 amino acids deriving from TERT protein, which peptide is capable of (i) binding to HLA class II and (ii) stimulating a CD4 Th response. These universal cancer peptides are especially useful in anti-tumor immunotherapy and immunomonitoring.

Find Patent Forward Citations

Langlade Demoyen, Pierre. (2020). Universal cancer peptides derived from telomerase (U.S. Patent No. 10695409). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10695409

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…